“…So, in addition to the several possible mechanisms of action cited above for alloimmune thrombocytopenia, inhibition of activation of the terminal complement cascade may be important in the action of antenatal IVIG therapy in GALD. Whatever the mechanism, wide experience suggests that it is effective in limiting the effect of GALD in pregnancies at risk [11,15,[21][22][23][24][25][26][27]. Although the extent of protection from fetal liver injury in GALD cannot be ascertained to the same degree as in alloimmune thrombocytopenia, where the platelet count is a direct measure of effectiveness, the results in the present study clearly demonstrate improved outcomes with IVIG treatment.…”